7ZOB image
Deposition Date 2022-04-25
Release Date 2023-02-01
Last Version Date 2024-02-07
Entry Detail
PDB ID:
7ZOB
Keywords:
Title:
Metagenomic cytidine deaminase Cdd
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
1.20 Å
R-Value Free:
0.16
R-Value Work:
0.14
R-Value Observed:
0.14
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Metagenomic cytidine deaminase Cdd
Chain IDs:A, B, C, D, E, F, G, H
Chain Length:140
Number of Molecules:8
Biological Source:uncultured bacterium
Primary Citation
Cytidine deaminases catalyze the conversion of N ( S , O ) 4 -substituted pyrimidine nucleosides.
Sci Adv 9 eade4361 eade4361 (2023)
PMID: 36735785 DOI: 10.1126/sciadv.ade4361

Abstact

Cytidine deaminases (CDAs) catalyze the hydrolytic deamination of cytidine and 2'-deoxycytidine to uridine and 2'-deoxyuridine. Here, we report that prokaryotic homo-tetrameric CDAs catalyze the nucleophilic substitution at the fourth position of N4-acyl-cytidines, N4-alkyl-cytidines, and N4-alkyloxycarbonyl-cytidines, and S4-alkylthio-uridines and O4-alkyl-uridines, converting them to uridine and corresponding amide, amine, carbamate, thiol, or alcohol as leaving groups. The x-ray structure of a metagenomic CDA_F14 and the molecular modeling of the CDAs used in this study show a relationship between the bulkiness of a leaving group and the volume of the binding pocket, which is partly determined by the flexible β3α3 loop of CDAs. We propose that CDAs that are active toward a wide range of substrates participate in salvage and/or catabolism of variously modified pyrimidine nucleosides. This identified promiscuity of CDAs expands the knowledge about the cellular turnover of cytidine derivatives, including the pharmacokinetics of pyrimidine-based prodrugs.

Legend

Protein

Chemical

Disease

Primary Citation of related structures